Glenmark Pharmaceuticals Limited
Held by 229 mutual fund schemes, ₹9,843Cr between them.
The largest single position is HDFC Mid Cap Fund (HDFC), which holds 3.1% of its portfolio in Glenmark Pharmaceuticals Limited — ₹3,224Cr, or 32.7% of all the mutual fund money in this stock.
The five largest holders account for 48% of it, across 229 schemes in total.
14 of the 60 largest holdings sit in arbitrage funds, the most of any category here.
Funds holding Glenmark Pharmaceuticals Limited
229Largest rupee position first, top 60 shown. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.
| Fund | Category | Weight | Position | Fund size |
|---|---|---|---|---|
| HDFC Mid Cap Fund | Mid Cap Fund | 3.06% | ₹3,224Cr | ₹1,05,346Cr |
| Invesco India Mid Cap Fund | Mid Cap Fund | 2.76% | ₹420.47Cr | ₹15,234Cr |
| Invesco India Contra Fund | Contra Fund | 2.03% | ₹408.67Cr | ₹20,132Cr |
| Quant ELSS Tax Saver Fund | ELSS | 2.73% | ₹364.91Cr | ₹13,377Cr |
| Invesco India Large & Mid Cap Fund | Large & Mid Cap Fund | 2.17% | ₹260.62Cr | ₹12,010Cr |
| Bandhan Large & Mid Cap Fund | Large & Mid Cap Fund | 1.28% | ₹259.73Cr | ₹20,292Cr |
| HDFC Large & Mid Cap Fund | Large & Mid Cap Fund | 0.86% | ₹256.83Cr | ₹29,864Cr |
| Kotak Arbitrage Fund | Arbitrage Fund | 0.30% | ₹224.55Cr | ₹74,848Cr |
| HDFC Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 0.20% | ₹213.54Cr | ₹1,06,770Cr |
| ICICI Prudential Arbitrage Fund | Arbitrage Fund | 0.60% | ₹208.83Cr | ₹34,615Cr |
| Bandhan Small Cap Fund | Small Cap Fund | 0.60% | ₹196.76Cr | ₹32,794Cr |
| Edelweiss Arbitrage Fund | Arbitrage Fund | 1.32% | ₹196.73Cr | ₹14,904Cr |
| UTI - Arbitrage Fund | Arbitrage Fund | 1.45% | ₹163.11Cr | ₹11,249Cr |
| Mirae Asset Healthcare Fund | Sectoral/ Thematic | 4.61% | ₹159.55Cr | ₹3,458Cr |
| UTI Nifty 200 Momentum 30 Index Fund | Index Funds | 1.78% | ₹149.23Cr | ₹8,384Cr |
| Tata Mid Cap Fund | Mid Cap Fund | 2.41% | ₹146.72Cr | ₹6,088Cr |
| HDFC Manufacturing Fund | Sectoral/ Thematic | 1.36% | ₹143.61Cr | ₹10,559Cr |
| Mahindra Manulife Mid Cap Fund | Mid Cap Fund | 2.65% | ₹139.18Cr | ₹5,252Cr |
| Nippon India Arbitrage Fund | Arbitrage Fund | 0.78% | ₹133.83Cr | ₹17,157Cr |
| Aditya Birla Sun Life Arbitrage Fund | Arbitrage Fund | 0.46% | ₹125.01Cr | ₹27,071Cr |
| Edelweiss Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 0.91% | ₹120.40Cr | ₹13,230Cr |
| Bandhan Focused Fund | Focused Fund | 4.94% | ₹103.98Cr | ₹2,105Cr |
| Axis Arbitrage Fund | Arbitrage Fund | 0.87% | ₹90.67Cr | ₹10,422Cr |
| HDFC Arbitrage Fund | Arbitrage Fund | 0.32% | ₹80.48Cr | ₹25,149Cr |
| Tata Arbitrage Fund | Arbitrage Fund | 0.32% | ₹79.01Cr | ₹24,691Cr |
| Axis Large & Mid Cap Fund | Large & Mid Cap Fund | 0.46% | ₹77.65Cr | ₹16,881Cr |
| Quant Multi Cap Fund | Multi Cap Fund | 0.93% | ₹71.72Cr | ₹7,721Cr |
| Mahindra Manulife Multi Cap Fund | Multi Cap Fund | 0.96% | ₹70.87Cr | ₹7,383Cr |
| Mahindra Manulife Small Cap Fund | Small Cap Fund | 1.28% | ₹67.23Cr | ₹5,252Cr |
| Mahindra Manulife Large & Mid Cap Fund | Large & Mid Cap Fund | 2.24% | ₹63.80Cr | ₹2,848Cr |
| HDFC Pharma and Healthcare Fund | Sectoral/ Thematic | 1.96% | ₹61.31Cr | ₹3,128Cr |
| Aditya Birla Sun Life Quant Fund | Sectoral/ Thematic | 3.01% | ₹60.12Cr | ₹2,000Cr |
| Nippon India Nifty Pharma ETF | Other ETFs | 3.42% | ₹58.15Cr | ₹1,700Cr |
| Invesco India Arbitrage Fund | Arbitrage Fund | 0.18% | ₹54.11Cr | ₹30,062Cr |
| Edelweiss Aggressive Hybrid Fund | Aggressive Hybrid Fund | 1.19% | ₹46.62Cr | ₹3,918Cr |
| Bandhan Arbitrage Fund | Arbitrage Fund | 0.58% | ₹46.31Cr | ₹7,984Cr |
| DSP Arbitrage fund | Arbitrage Fund | 0.69% | ₹46.18Cr | ₹6,693Cr |
| Mirae Asset Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.46% | ₹43.39Cr | ₹9,512Cr |
| HSBC Arbitrage Fund | Arbitrage Fund | 1.21% | ₹38.35Cr | ₹3,170Cr |
| Bandhan Mid Cap Fund | Mid Cap Fund | 1.54% | ₹38.17Cr | ₹2,479Cr |
| Edelweiss Nifty Midcap150 Momentum 50 Index Fund | Index Funds | 2.12% | ₹37.36Cr | ₹1,762Cr |
| JM Mid Cap Fund | Mid Cap Fund | 2.75% | ₹36.33Cr | ₹1,319Cr |
| Motilal Oswal Nifty Midcap 150 Index Fund | Index Funds | 0.89% | ₹35.56Cr | ₹3,995Cr |
| Nippon India ETF Nifty Midcap 150 | Other ETFs | 0.89% | ₹34.27Cr | ₹3,850Cr |
| Baroda BNP Paribas Arbitrage Fund | Arbitrage Fund | 3.15% | ₹34.26Cr | ₹1,088Cr |
| HDFC Dividend Yield Fund | Dividend Yield Fund | 0.58% | ₹32.41Cr | ₹5,588Cr |
| Edelweiss Business Cycle Fund | Sectoral/ Thematic | 2.20% | ₹31.51Cr | ₹1,432Cr |
| UTI - Healthcare Fund | Sectoral/ Thematic | 2.08% | ₹29.10Cr | ₹1,399Cr |
| Axis Multicap Fund | Multi Cap Fund | 0.25% | ₹28.58Cr | ₹11,430Cr |
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Index Funds | 2.16% | ₹26.52Cr | ₹1,228Cr |
| Bandhan Innovation Fund | Sectoral/ Thematic | 0.89% | ₹24.98Cr | ₹2,807Cr |
| Nippon India Nifty Midcap 150 Index Fund | Index Funds | 0.89% | ₹24.49Cr | ₹2,752Cr |
| Mahindra Manulife Business Cycle Fund | Sectoral/ Thematic | 1.63% | ₹21.99Cr | ₹1,349Cr |
| Nippon India Nifty 500 Momentum 50 Index Fund | Index Funds | 1.67% | ₹21.39Cr | ₹1,281Cr |
| JioBlackRock Flexi Cap Fund | Flexi Cap Fund | 0.62% | ₹20.28Cr | ₹3,250Cr |
| Bandhan Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.72% | ₹17.97Cr | ₹2,496Cr |
| Baroda BNP Paribas Innovation Fund | Sectoral/ Thematic | 1.97% | ₹17.69Cr | ₹898.13Cr |
| Invesco India Business Cycle Fund | Sectoral/ Thematic | 1.31% | ₹17.42Cr | ₹1,330Cr |
| Motilal Oswal Nifty 200 Momentum 30 Index Fund | Index Funds | 1.78% | ₹16.78Cr | ₹942.44Cr |
| UTI Multi Cap Fund | Multi Cap Fund | 0.78% | ₹16.63Cr | ₹2,132Cr |
Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM, available for 217 of the 229 holders. Nothing here is advice, and a stock being widely held is not an argument for owning it.
Funds buying and selling Glenmark Pharmaceuticals Limited
In their latest monthly disclosure, 30 funds bought and 28 sold, judged by share count.
Frequently asked questions
Which mutual fund holds the most Glenmark Pharmaceuticals Limited?
By rupee value, HDFC Mid Cap Fund from HDFC — ₹3,224Cr, at 3.1% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.
Which fund has the highest weight in Glenmark Pharmaceuticals Limited?
Bandhan Focused Fund carries the largest weight at 4.9% of its portfolio. That is a different question from the largest rupee position — a small fund can hold a much bigger share of itself in one stock than a large fund does.
How many mutual funds hold Glenmark Pharmaceuticals Limited?
229 schemes, holding ₹9,843Cr between them across the 217 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.
Does a fund holding Glenmark Pharmaceuticals Limited make it a good investment?
No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.